Results vary based on individual skin type, dosage and treatment frequency
Over the years, we have developed a reputation for focusing on value, integrity, experience, and quality
Ali, I want to go back to, I want to talk about the physical retail store and I want to go back to something you had said in your study that you did and that was this, physical retail has a opportunity and that opportunity lies in the fact that a lot of the GLP-1 users, you know, they are emotionally connected, they want to be in the store, theyre unsure of what sizes to buy and so there we have a golden opportunity for physical retail
This can be an important distinction for people who dont want to give themselves weekly injections
The Judicial Panel on Multidistrict Litigation (JPML) published an order on December 15, 2025, approving a request to create a dedicated MDL for blindness claims filed by patients who took Zepbound or other GLP-1s
The MHRA Drug Safety Update (2022) highlights this association and recommends considering periodic monitoring in at-risk patients